This study is currently not recruiting participants.

The Efficacy and Safety of Bimatoprost Sustained Release

  • STATUS
    Not Recruiting
Send
Updated on 19 February 2024

Summary

The purpose of this study is to investigate the safety and effectiveness of two different dose strengths in lowering eye pressure in subjects with glaucoma or high eye-pressure.The Bimatoprost sustained release (SR) is a small implant placed inside the eye. It dissolves naturally in the body and contains the bimatoprost drug. The drug is slowly released for about 3 to 4 months.

Description

All subjects who take part in this study will get Timolol 0.5% eye drops to use in the eye(s) that do not receive Bimatoprost SR.

FAQ

There may be up to 25 visits to the study doctor's clinic and 6 phone calls from your study doctor for 22 months. These 22 months are made up of 52 weeks of a study treatment time frame, and then an 8 month extended follow-up.

Details
Condition Glaucoma, Hypertension, hypertension, Open-Angle Glaucoma, ocular
Age 18years - 99years
Clinical Study Identifier02247805
Last Modified on19 February 2024

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.